Different adhesive characteristics and VLA-4 expression of CD34(+) progenitors in G0/G1 versus S+G2/M phases of the cell cycle.
暂无分享,去创建一个
M. Yamaguchi | F. Hirayama | T. Koike | K. Sawada | K. Ikebuchi | S. Sekiguchi | Y. Yoshikawa | N. Sato | Y. Mogi | J. Ohkawara
[1] A. Tsukamoto,et al. The unexpected G0/G1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood. , 1997, Blood.
[2] J. Franco,et al. Quantitative and cell-cycle differences in progenitor cells mobilized by recombinant human interleukin-7 and recombinant human granulocyte colony-stimulating factor. , 1996, Blood.
[3] C. Hillyer,et al. Peripheral blood progenitor cells for marrow reconstitution: mobilization and collection strategies , 1996, Transfusion.
[4] S. Hanauer,et al. A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cells. , 1996, Experimental hematology.
[5] J. Bourhis,et al. Successful pregnancy after allogeneic bone marrow transplantation following conditioning including a 10-Gy single exposure total body irradiation. , 1996, Bone marrow transplantation.
[6] R. Donahue,et al. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. , 1996, Blood.
[7] A. Roberts,et al. Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. , 1995, Blood.
[8] J. Bourhis,et al. Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma. , 1995, Bone marrow transplantation.
[9] D. Huhn,et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] M. Vadas,et al. Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins , 1995, The Journal of experimental medicine.
[11] J. Oliver,et al. Signals from platelet/endothelial cell adhesion molecule enhance the adhesive activity of the very late antigen-4 integrin of human CD34+ hemopoietic progenitor cells. , 1994, Journal of immunology.
[12] S. Asano,et al. A time course study for optimal harvest of peripheral blood progenitor cells by granulocyte colony-stimulating factor in healthy volunteers. , 1994, Experimental hematology.
[13] F. Appelbaum,et al. In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells. , 1994, Blood.
[14] R. Andrews,et al. Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. , 1994, Blood.
[15] W. Hittelman,et al. Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Y. Humblet,et al. Tolerance of sequential or simultaneous administration of IL-3 and G-CSF in improving peripheral blood stem cells harvesting following multi-agent chemotherapy: a pilot study. , 1994, Bone marrow transplantation.
[17] T. Papayannopoulou,et al. Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[18] R. Andrews,et al. The role of stem cell factor in mobilization of peripheral blood progenitor cells: Synergy with G‐CSF , 1993, Stem cells.
[19] G D Long,et al. Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. , 1993, Blood.
[20] R. M. Fox,et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy , 1992, The Lancet.
[21] L. Kanz,et al. Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin. , 1992, Blood.
[22] David A. Williams,et al. Fibronectin and VLA-4 in haematopoietic stem cell–microenvironment interactions , 1991, Nature.
[23] D. Williams,et al. Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[24] A. Ho,et al. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. , 1990, Experimental hematology.
[25] K. Nagata,et al. Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. , 1989, Experimental hematology.
[26] F. Appelbaum,et al. Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates , 1995 .
[27] A. Goldstone,et al. Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: a case-controlled analysis of the EBMT Registry data. Lymphoma Working Party of the EBMT. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.